Neuroaetiology of chronic fatigue syndrome: an overview
- PMID: 17853290
- DOI: 10.1080/15622970701310971
Neuroaetiology of chronic fatigue syndrome: an overview
Abstract
Chronic fatigue syndrome (CFS) is now recognized as a medial disorder. In contrast to recent related reports, the present review focuses primarily on aetiological aspects of CFS. Four major hypotheses are reviewed. (1) Although CFS is often associated with viral infection, the presence of viruses has as yet not consistently been detected. (2) It is not clear whether anomalies of the HPA axis often observed in CFS, are cause or the consequences of the disorder. (3) Immune dysfunction as the cause of CFS is thus far the weakest hypothesis. (4) The psychiatric and psychosocial hypothesis denies the existence of CFS as a disease entity. Accordingly, the fatigue symptoms are assumed to be the consequence of other (somatic) diseases. Other possible causes of CFS are oxidative stress and genetic predisposition. In CFS cognitive behavioural therapy is most commonly used. This therapy, however, appears to be ineffective in many patients. The suggested causes of CFS and the divergent reactions to therapy may be explained by the lack of recognition of subgroups. Identification of subtypes may lead to more effective therapeutic interventions.
Similar articles
-
The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.Stress. 2007 Mar;10(1):13-25. doi: 10.1080/10253890601130823. Stress. 2007. PMID: 17454963 Review.
-
The HPA axis and the genesis of chronic fatigue syndrome.Trends Endocrinol Metab. 2004 Mar;15(2):55-9. doi: 10.1016/j.tem.2003.12.002. Trends Endocrinol Metab. 2004. PMID: 15036250 Review.
-
Does hypothalamic-pituitary-adrenal axis hypofunction in chronic fatigue syndrome reflect a 'crash' in the stress system?Med Hypotheses. 2009 Jun;72(6):701-5. doi: 10.1016/j.mehy.2008.11.044. Epub 2009 Feb 23. Med Hypotheses. 2009. PMID: 19237251
-
Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.Psychol Med. 2008 Jul;38(7):963-73. doi: 10.1017/S0033291707001444. Epub 2007 Sep 6. Psychol Med. 2008. PMID: 17803834
-
Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.J Psychosom Res. 2004 Apr;56(4):419-24. doi: 10.1016/S0022-3999(03)00625-1. J Psychosom Res. 2004. PMID: 15094026
Cited by
-
Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.Br J Pharmacol. 2017 Mar;174(5):345-369. doi: 10.1111/bph.13702. Epub 2017 Feb 1. Br J Pharmacol. 2017. PMID: 28052319 Free PMC article. Review.
-
Protective effects of selective and non-selective cyclooxygenase inhibitors in an animal model of chronic stress.Neurosci Bull. 2010 Feb;26(1):17-27. doi: 10.1007/s12264-010-0713-x. Neurosci Bull. 2010. PMID: 20101269 Free PMC article.
-
Chiropractic Management of a Patient With Chronic Fatigue: A Case Report.J Chiropr Med. 2016 Dec;15(4):314-320. doi: 10.1016/j.jcm.2016.08.006. Epub 2016 Oct 18. J Chiropr Med. 2016. PMID: 27857641 Free PMC article.
-
A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data.J Transl Med. 2009 Sep 22;7:81. doi: 10.1186/1479-5876-7-81. J Transl Med. 2009. PMID: 19772600 Free PMC article.
-
DNA methylation modifications associated with chronic fatigue syndrome.PLoS One. 2014 Aug 11;9(8):e104757. doi: 10.1371/journal.pone.0104757. eCollection 2014. PLoS One. 2014. PMID: 25111603 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical